The future of non-opioid drug development, including potential enlargement of suzetrigine’s indications for Continual pain, may hinge over the Trump administration’s approach to health care innovation. Antiepileptic medications: Equally gabapentin and pregabalin are ligands to the ?? subunit from the voltage-dependent calcium channels, which